Alpha 2.0
Login Register
» Articles » PMID: 16672414

Sensitivity of the Multispot HIV-1/HIV-2 Rapid Test Using Samples from Human Immunodeficiency Virus Type 1-positive Individuals with Various Levels of Exposure to Highly Active Antiretroviral Therapy

Overview
Journal J Clin Microbiol
Specialty Microbiology
Date 2006 May 5
PMID 16672414
Citations 6
Authors
Robert J OConnell
Brian K Agan
Stephanie A Anderson
Jennifer A Malia
Nelson L Michael
Affiliations
Soon will be listed here.
Abstract

The Multispot HIV-1/HIV-2 rapid test detects human immunodeficiency virus type 1 (HIV-1) gp41 antibodies, which can wane over time in some HIV-1-infected populations, resulting in false-negative screening results. Multispot sensitivity was 100% using 248 sera from one such population, and it correctly identified serostatus in individuals who previously tested false negative with rapid testing.

Citing Articles

Rapid tests should be used with caution for HIV-1 primary infection screening.

Guiraud V, Beaulieu Q, Fauchois A, Jean-Charles P, Costes M, Labousse B Med Microbiol Immunol. 2024; 213(1):10.

PMID: 38907945 DOI: 10.1007/s00430-024-00792-1.

Influence of Combination Antiretroviral Therapy on HIV-1 Serological Responses and Their Implications: A Systematic Review and Meta-Analysis.

Liang Y, Lin H, Dzakah E, Tang S Front Immunol. 2022; 13:844023.

PMID: 35432309 PMC: 9006953. DOI: 10.3389/fimmu.2022.844023.

HIV-1/2 differentiation in a South African public laboratory.

Mafuyeka R, Webber L, Becker P, Mayaphi S South Afr J HIV Med. 2021; 22(1):1185.

PMID: 33824732 PMC: 8008004. DOI: 10.4102/sajhivmed.v22i1.1185.

Does antiretroviral therapy use affect the accuracy of HIV rapid diagnostic assays? Experience from a demographic health and surveillance site in rural South Africa.

Siedner M, Baisley K, Koole O, Mpofana I, Ording-Jespersen G, Matthews P Diagn Microbiol Infect Dis. 2020; 97(2):115031.

PMID: 32178904 PMC: 7262582. DOI: 10.1016/j.diagmicrobio.2020.115031.

Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa.

Bock P, Phiri C, Piwowar-Manning E, Kosloff B, Mandla N, Young A J Int AIDS Soc. 2017; 20(Suppl 6):21780.

PMID: 28872272 PMC: 5625636. DOI: 10.7448/IAS.20.7.21780.

References
1.
Holguin A . Evaluation of three rapid tests for detection of antibodies to HIV-1 non-B subtypes. J Virol Methods. 2003; 115(1):105-7. DOI: 10.1016/j.jviromet.2003.09.028. View
2.
OConnell R, Merritt T, Malia J, VanCott T, Dolan M, Zahwa H . Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol. 2003; 41(5):2153-5. PMC: 154669. DOI: 10.1128/JCM.41.5.2153-2155.2003. View
3.
Morris L, Binley J, Clas B, Bonhoeffer S, Astill T, Kost R . HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med. 1998; 188(2):233-45. PMC: 2212446. DOI: 10.1084/jem.188.2.233. View
4.
Phillips S, Granade T, Pau C, Candal D, Hu D, Parekh B . Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests. Clin Diagn Lab Immunol. 2000; 7(4):698-9. PMC: 95937. DOI: 10.1128/CDLI.7.4.698-699.2000. View
5.
Pitcher C, Quittner C, Peterson D, Connors M, Koup R, Maino V . HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med. 1999; 5(5):518-25. DOI: 10.1038/8400. View